Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

Stopped Sponsor decided to end long term extension phase for business reasons unrelated to safety.

Conditions

• Rheumatoid Arthritis

Interventions

• BIOLOGICAL: IDEC-C2B8 (rituximab)
• DRUG: Placebo
• DRUG: Methotrexate
• DRUG: Etanercept
• DRUG: Adalimumab
• DRUG: Methylprednisolone
• DIETARY_SUPPLEMENT: Folate

Sponsor

Biogen

Collaborators

• [object Object]
• [object Object]